Skip to main content
editorial
. 2015 Sep 16;14(21):3345–3346. doi: 10.1080/15384101.2015.1093443

Figure 1.

Figure 1.

The role of DOT1L in cell reprogramming and aging. The methylation mark H3K79 increases with the inflammatory state associated with aging. Treatment with NF-κB or DOT1L inhibitors reduces the epigenetic mark H3K79 and leads to a rejuvenated state which ameliorates the reprogramming efficiency of aged cells and the age-associated features related with accelerated aging syndromes.